» Articles » PMID: 35283520

HPV Vaccination Status and Resolution of Warts in Pediatric Patients

Overview
Specialty Dermatology
Date 2022 Mar 14
PMID 35283520
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Warts are a common dermatologic complaint with an increased incidence within the pediatric population. Warts are caused by multiple strains of the human papillomavirus (HPV). There is little research on how a patient's HPV immunization status affects the response to treatment of warts in pediatric patients.

Aims: The purpose of this study is to investigate the relationship between HPV vaccination status and wart resolution.

Materials And Methods: This is a retrospective chart review that investigates the relationship between response to routine treatment of warts and a subject's HPV vaccination status.

Results: There was no significant relationship found between HPV vaccination status and resolution of warts ( = 0.797). However, there was a significant positive correlation between having the HPV vaccine and number of visits for the treatment of warts ( = 0.180, = 0.024).

Conclusion: This study did not show a significant correlation between HPV vaccination status and wart resolution, although it demonstrated a significant positive relationship between those immunized with the HPV vaccine and an increased number of treatment visits. Possible explanations for this unexpected correlation include the variation in HPV vaccine formulation, vaccination status, and frequency of office visits, since vaccinated patients are more likely to be compliant with office visits.

References
1.
Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

2.
Yanofsky V, Patel R, Goldenberg G . Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012; 5(6):25-36. PMC: 3390234. View

3.
Malo T, Giuliano A, Kahn J, Zimet G, Lee J, Zhao X . Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):2126-35. PMC: 4184998. DOI: 10.1158/1055-9965.EPI-14-0344. View

4.
Kost Y, Zhu T, Blasiak R . Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine. Pediatr Dermatol. 2020; 37(4):748-749. DOI: 10.1111/pde.14150. View

5.
Fox P, Tung M . Human papillomavirus: burden of illness and treatment cost considerations. Am J Clin Dermatol. 2005; 6(6):365-81. DOI: 10.2165/00128071-200506060-00004. View